Company Overview
Snapshot
Founded in June 2023 by Guy Attar and Erez Shmueli, Wizermed operates with 1–10 employees. The company has raised $3M across one funding round. In February 2024, Wizermed secured Seed funding from eHealth Ventures.
Business overview
Wizermed develops a solution to help migraine sufferers manage their condition and improve their quality of life. The company's core technology involves continuously monitoring signals from a user's smartwatch to predict migraine attacks up to 24 hours in advance. A mobile application then provides early warnings and personalized insights, enabling users to take preventive measures. Wizermed operates within the Health Tech & Life Sciences sector, specifically focusing on Digital Healthcare and Patient Engagement, serving consumers and healthcare patients.
Strategic signal
In May 2024, Wizermed added new members to its Board of Directors, signaling a strategic move to strengthen its leadership and governance. This expansion suggests the company is preparing for further growth and development, leveraging experienced professionals to guide its trajectory in the digital health and migraine management market.
Log in to access full profile ›Company Intelligence Q&A
- When was Wizermed founded?
- Wizermed was founded in June 2023 by Guy Attar and Erez Shmueli.
- What is Wizermed's primary focus?
- Wizermed focuses on providing wise solutions for migraine management, utilizing technology to predict and help users prepare for migraine attacks.
- What is the company's employee count?
- Wizermed currently has 1–10 employees.
- What was a significant development for Wizermed in May 2024?
- In May 2024, Wizermed announced new additions to its Board of Directors, indicating a strengthening of its leadership team and preparing for further growth.
- Which investor participated in Wizermed's Seed funding round?
- In February 2024, Wizermed secured Seed funding from eHealth Ventures, raising $3M in this round.